Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.235 USD | -5.13% | -9.89% | -45.35% |
Apr. 04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
Jan. 08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
- Stock Market
- Equities
- MURA Stock
- News Mural Oncology plc